Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „XTEN“
Suchtreffer
Begriffe & Kennungen
Brintellix · 4.5 · Vortioxetine is extensively metabolised in the liver, primarily through oxidation catalysed by CYP2D6 and to a
Eintrag öffnenBrintellix · 4.5 · Vortioxetine is extensively metabolised in the liver, primarily through oxidation catalysed by CYP2D6 and to a
Eintrag öffnenBrintellix · 4.8 · Two long-term open-label extension studies were performed with vortioxetine doses of 5 to 20 mg/day, and with
Eintrag öffnenBrintellix · 4.8 · Two long-term open-label extension studies were performed with vortioxetine doses of 5 to 20 mg/day, and with
Eintrag öffnenCelsentri · 4.8 · The MOTIVATE studies were extended beyond 96 weeks, with an observational phase extended to 5 years in order t
Eintrag öffnenCelsentri · 4.8 · The MOTIVATE studies were extended beyond 96 weeks, with an observational phase extended to 5 years in order t
Eintrag öffnenCerdelga · 4.5 · Eliglustat is metabolised primarily by CYP2D6 and to a lesser extent by CYP3A4. Concomitant administration of
Eintrag öffnenCholestagel · 4.5 · Antidiabetic agents Co-administration of colesevelam and metformin extended-release (ER) tablets increases the
Eintrag öffnenCibinqo · 4.5 · Abrocitinib is metabolised predominantly by CYP2C19 and CYP2C9 enzymes, and to a lesser extent by CYP3A4 and C
Eintrag öffnenDauerkontaktlinsen
Eintrag öffnenDegevma · 4.8 · 8 The trials in patients with breast or prostate cancer included a denosumab extension treatment phase (median
Eintrag öffnenDepotpräparate
Eintrag öffnenDiacomit · 4.5 · - Levetiracetam Levetiracetam does not undergo hepatic metabolism to a major extent. As a result, no pharmacok
Eintrag öffnenDiacomit · 4.5 · - Levetiracetam Levetiracetam does not undergo hepatic metabolism to a major extent. As a result, no pharmacok
Eintrag öffnenDiacomit · 4.5 · - Levetiracetam Levetiracetam does not undergo hepatic metabolism to a major extent. As a result, no pharmacok
Eintrag öffnenDiacomit · 4.5 · - Levetiracetam Levetiracetam does not undergo hepatic metabolism to a major extent. As a result, no pharmacok
Eintrag öffnenDupixent · 4.8 · 14 The long-term safety of dupilumab was assessed in an open-label extension study (EXCURSION) in children 6 t
Eintrag öffnenDupixent · 4.8 · In a phase 3, multicentre, open label extension (OLE) study (AD-1225), the long-term safety of repeat doses of
Eintrag öffnenDupixent · 4.8 · In a phase 3, multicentre, open label extension (OLE) study (AD-1225), the long-term safety of repeat doses of
Eintrag öffnenDupixent · 4.8 · The long-term safety of dupilumab was assessed in an open-label extension study (EXCURSION) in children 6 to 1
Eintrag öffnen